Sarepta Therapeutics Q2 2021 Earnings Preview
- Sarepta Therapeutics (NASDAQ:SRPT) is scheduled to announce Q2 earnings results on Wednesday, August 4th, after market close.
- The consensus EPS Estimate is -$1.29 (+14.6% Y/Y) and the consensus Revenue Estimate is $162.09M (+18.0% Y/Y).
- Over the last 2 years,…
